tear trough: Definition, Uses, and Clinical Overview

Definition (What it is) of tear trough

The tear trough is a natural indentation that runs from the inner corner of the eye along the upper cheek.
It is also called the nasojugal groove and is part of normal under-eye anatomy.
In cosmetic medicine, “tear trough” commonly refers to visible under-eye hollowing or shadowing in this area.
It is used mainly in cosmetic assessment and treatment planning, and sometimes in reconstructive evaluation after trauma or surgery.

Why tear trough used (Purpose / benefits)

The tear trough region matters because it strongly influences how the under-eye area looks in different lighting and facial expressions. When the groove is pronounced, it can create shadowing that people describe as “dark circles,” “tired-looking eyes,” or under-eye “hollows,” even when overall health and sleep are normal.

In clinical practice, the term tear trough is used in two related ways:

• As an anatomic landmark: Clinicians use it to describe where the lower eyelid transitions to the cheek and how the eyelid-cheek junction is shaped.
• As a treatment target: Treatments may aim to soften the eyelid-cheek transition, reduce the appearance of shadowing, and improve perceived symmetry between the two sides.

Potential benefits of addressing the tear trough area (with appropriate patient selection and technique) can include:

• A smoother transition between the lower eyelid and cheek
• Reduced shadowing that contributes to the “dark circle” appearance
• A more balanced midface contour when under-eye hollowing is part of broader volume loss
• Improved harmony between the eyes and surrounding facial structures (cheek, nose, and lid margin)

Importantly, under-eye appearance is multifactorial. Pigment, skin thickness, visible blood vessels, cheek support, eyelid laxity, and herniated orbital fat can all contribute, so “treating the tear trough” may mean different things in different patients.

Indications (When clinicians use it)

Common scenarios where clinicians evaluate or treat the tear trough region include:

• Visible under-eye hollowing that creates a noticeable groove or indentation
• Shadowing under the eyes that is primarily contour-related (not only pigment-related)
• Age-related volume loss in the midface with a sharper eyelid-cheek junction
• Congenital or long-standing under-eye hollowness (present since youth)
• Asymmetry between the two under-eye areas due to anatomy or prior procedures
• Post-traumatic or post-surgical contour irregularities affecting the lid-cheek transition
• Under-eye contour concerns occurring alongside cheek volume loss (where combined planning may be considered)

Contraindications / when it’s NOT ideal

Not every under-eye concern is a tear trough problem, and not every tear trough is best treated with volume. Situations where tear trough–focused treatment may be less suitable, or where a different approach may be preferred, include:

• Significant lower eyelid skin laxity or “crepey” skin where volume alone may not address texture
• Prominent under-eye fluid swelling (edema), malar edema, festoons, or malar bags, which can look worse if additional volume is added
• Marked lower eyelid laxity (for example, when the lid position is unstable), where surgical evaluation may be more relevant
• Very thin skin with high risk of visible product contour (aesthetic risk varies by clinician and case)
• Active skin infection or inflammation near the treatment area (procedures are typically deferred)
• History of significant bleeding issues or unmanaged medical conditions that increase procedural risk (exact relevance varies by clinician and case)
• Unrealistic expectations (for example, expecting one treatment to fully correct pigment, texture, and anatomy simultaneously)
• Prior complications in the under-eye region (such as prolonged swelling or contour irregularity), where a cautious reassessment is often needed
• When the main issue is pigment or vascular show rather than contour, where skin-focused modalities may be more appropriate

How tear trough works (Technique / mechanism)

“Tear trough” is an anatomic region, not a single procedure. In practice, clinicians address it using minimally invasive and/or surgical approaches depending on the cause of the hollowing or shadow.

At a high level, mechanisms include:

• Restoring volume: Adding volume to reduce the depth of the groove and soften the shadowing.
• Repositioning tissue: Moving existing fat to smooth the eyelid-cheek transition rather than adding volume.
• Removing or reshaping protruding fat: In selected cases where bulging fat pads contribute to contour issues.
• Tightening and resurfacing (adjunctive): Improving skin texture or fine lines when these contribute to the under-eye appearance. These methods do not “fill” a tear trough but may complement contour treatments.

Common modalities and tools include:

• Injectables (minimally invasive): Most commonly hyaluronic acid (HA) dermal fillers in many practices; technique and product selection vary by clinician and case. Cannulas or needles may be used depending on clinician preference and anatomy.
• Autologous fat transfer (minimally invasive to surgical): Using a patient’s own fat to restore volume; survival and integration vary by technique and patient factors.
• Lower eyelid surgery (surgical): Variations of lower blepharoplasty may involve fat repositioning, fat reduction, skin tightening, and support of the lower lid, depending on the problem being treated.
• Energy-based and resurfacing treatments (adjunctive): Laser resurfacing, chemical peels, or radiofrequency-based treatments may be used to address fine lines or skin quality when appropriate. These are not direct “tear trough” fillers but can influence how the under-eye area looks.

Because the under-eye region contains delicate structures and important blood vessels, clinicians generally emphasize precision in depth, plane, and product choice. The exact technique is highly individualized and varies by clinician and case.

tear trough Procedure overview (How it’s performed)

While the details differ by method (injectable vs surgical), a general workflow often looks like this:

1. Consultation – Discussion of goals, what bothers the patient, and what changes are realistic for the anatomy. – Review of medical history and prior procedures that may affect planning.

2. Assessment / planning – Facial analysis in different lighting and angles, including the relationship between lower eyelid, cheek support, and midface volume. – Determining whether the dominant issue is hollowing, bulging fat, skin laxity, pigment, swelling, or a combination. – Selection of an approach (for example, filler, fat transfer, lower blepharoplasty, resurfacing, or combined strategies).

3. Prep / anesthesia – For injectables: topical anesthetic and/or local anesthetic may be used; some fillers include anesthetic (varies by material and manufacturer). – For surgery: anesthesia may range from local anesthesia with sedation to general anesthesia, depending on the plan and setting.

4. Procedure – Injectables: Product is placed in targeted areas to support the lid-cheek junction while aiming for a smooth contour. – Fat transfer: Fat is harvested, processed, and placed in small amounts to build volume gradually. – Lower blepharoplasty: The surgeon addresses eyelid fat and skin based on the chosen technique, which may include repositioning fat to fill the groove.

5. Closure / dressing – Injectables typically require no sutures; clinicians may use cooling measures or protective instructions. – Surgical approaches may involve sutures, ointment, and eye-area dressings depending on technique.

6. Recovery – Short-term swelling and bruising are common after injectables and surgery, with recovery patterns varying widely. – Follow-up may be scheduled to assess healing, symmetry, and whether refinements are appropriate.

Types / variations

Approaches to the tear trough region can be grouped in several practical ways.

Surgical vs non-surgical (or minimally invasive)

• Non-surgical / minimally invasive: Most commonly dermal filler; may also include skin-focused modalities for texture or pigment concerns.
• Surgical: Lower blepharoplasty (with or without fat repositioning) and related eyelid-cheek junction procedures.

Volume addition vs tissue repositioning

• Volume addition: HA filler or fat transfer to reduce the depth of the tear trough and smooth transitions.
• Tissue repositioning: Surgical fat repositioning can move existing orbital fat to the hollow area, aiming to correct bulge-and-hollow patterns in a single concept.

Access approach (primarily for surgery)

• Transconjunctival approach: Access through the inside of the lower eyelid; often discussed when skin removal is not the main goal.
• Transcutaneous approach: Access through an external incision near the lash line; may be considered when skin tightening or muscle work is part of the plan. Technique selection varies by clinician and case.

Needle vs cannula (primarily for filler)

• Needle-based placement: Allows precise placement in small areas but depends heavily on technique.
• Cannula-based placement: Uses a blunt-tipped cannula through a small entry point; some clinicians prefer it for certain planes and safety considerations. Preference varies by clinician and case.

Anesthesia choices

• Injectables: Often performed with topical and/or local anesthesia.
• Fat transfer / surgery: Local with sedation or general anesthesia may be used depending on the extent of work, patient factors, and facility protocols.

Pros and cons of tear trough

Pros:

• Can address under-eye shadowing caused by contour changes, not just skin color
• May improve the eyelid-cheek transition and perceived facial balance
• Minimally invasive options are available for selected candidates
• Surgical options can address combined problems (for example, bulging fat and hollowing) in some cases
• Treatment planning can be customized to anatomy (volume, lid support, skin quality)
• Can be combined with other facial procedures when clinically appropriate

Cons:

• The under-eye area is anatomically delicate, and outcomes can be technique-sensitive
• Swelling, bruising, and temporary asymmetry can occur, especially early in recovery
• Some causes of “dark circles” (pigment, vessels, thin skin) may not respond to volume-based correction alone
• Overcorrection, contour irregularities, or visible product can occur, particularly in thin skin (risk varies by clinician and case)
• Some patients are prone to persistent puffiness or fluid retention in the malar region, which may limit options
• Longevity is variable and depends on anatomy, method, and product or technique
• Revision or additional procedures may be needed in complex cases or after prior treatments

Aftercare & longevity

Aftercare and longevity depend on what “tear trough treatment” means in a given case (filler, fat transfer, surgery, or adjunctive skin treatments). In general, clinicians discuss a combination of early recovery expectations and longer-term maintenance.

What typically influences longevity

• Technique and placement plane: Subtle differences in depth and distribution can change both appearance and how long results seem to last.
• Material characteristics: For fillers, longevity varies by material and manufacturer, and by how the product behaves in thin under-eye tissues.
• Individual anatomy and metabolism: People break down fillers at different rates, and swelling tendencies vary.
• Skin quality and thickness: Thin, lax, or photodamaged skin may show contour changes more easily over time.
• Midface support: Cheek volume loss and descent can contribute to recurrence of the trough appearance even after under-eye correction.
• Lifestyle and environmental factors: Sun exposure and smoking can affect skin quality; overall aging continues regardless of procedure.

General aftercare themes (non-prescriptive)

• It is common for clinicians to recommend monitoring for swelling, bruising, and asymmetry during the early healing phase.
• Follow-up helps document healing and determine whether a staged approach is needed, particularly with volume-based methods.
• For surgical approaches, recovery can involve a longer period of visible healing, and final contour may take time to settle.

Because products, techniques, and individual healing vary, clinicians typically frame durability and maintenance as individualized rather than guaranteed.

Alternatives / comparisons

Concerns attributed to the tear trough can come from multiple sources, so alternatives often target different mechanisms.

Tear trough filler vs cheek (midface) filler

• Under-eye hollowing sometimes reflects reduced cheek support. In some cases, treating the midface first can indirectly soften the tear trough by improving the lid-cheek relationship.
• Direct tear trough filling focuses on the groove itself but may be less suitable if swelling risk is high or if the main deficit is structural support lower in the cheek.

Filler vs autologous fat transfer

• Fillers are adjustable and commonly performed in-office, but longevity varies by product and patient factors.
• Fat transfer uses the patient’s own tissue and can provide longer-lasting volume in some cases, but take/survival is variable, and the procedure is more involved.

Non-surgical contour correction vs lower blepharoplasty

• Non-surgical methods focus on volume and camouflage and typically involve less immediate downtime than surgery, but may not address prominent fat bulges or lid laxity.
• Lower blepharoplasty can address structural issues (fat herniation, skin excess, lid support) when indicated, but involves surgical recovery and scarring considerations based on approach.

Volume correction vs skin-directed treatments

• If the dominant issue is fine lines, crepey texture, or pigment, resurfacing or skin-quality treatments may be considered instead of—or in addition to—volume restoration.
• Skin treatments may improve texture and tone but generally do not replace lost volume or correct deeper contour changes on their own.

Camouflage (makeup, skincare) vs procedural options

• Cosmetic camouflage can reduce the appearance of shadow and discoloration without procedural risks.
• Procedures may change underlying contours or tissue relationships, but outcomes vary and require careful candidate selection.

Common questions (FAQ) of tear trough

Q: Is the tear trough a medical condition or a normal feature?
The tear trough is a normal anatomic groove at the junction of the lower eyelid and cheek. Some people have a more visible tear trough due to genetics, facial structure, or aging-related volume changes. Clinicians may refer to it as a “deformity” when it is prominent and cosmetically concerning, but it can also be a normal variant.

Q: What causes a more noticeable tear trough?
Visibility can increase with midface volume loss, thinning skin, changes in ligament support, and shifts in fat compartments over time. Lighting and facial expression can accentuate shadowing. In some people it is present from youth due to bone and soft-tissue anatomy.

Q: Does treating the tear trough fix dark circles?
Sometimes, but not always. If “dark circles” are mainly from shadowing due to hollowing, contour correction may help. If the darkness is primarily pigment, visible vessels, or thin skin, results may be limited and other modalities may be considered.

Q: Is tear trough treatment painful?
Discomfort varies by method and individual sensitivity. Many minimally invasive treatments use topical or local anesthetic to improve comfort, and surgical options use more comprehensive anesthesia. Post-procedure soreness or tightness can occur, depending on the approach.

Q: What anesthesia is typically used?
For injectables, clinicians commonly use topical anesthetic, local anesthetic, or filler that contains anesthetic (varies by material and manufacturer). For surgical correction, anesthesia may be local with sedation or general anesthesia, depending on the planned technique and setting. Choice varies by clinician and case.

Q: Will there be scarring?
With injectable approaches, there is typically no incision and therefore no surgical scar. With surgery, scarring depends on the approach: some incisions are placed inside the eyelid, while others are placed near the lash line. How noticeable scars become varies by skin type, technique, and healing.

Q: What is the downtime like?
Downtime varies by procedure and by individual bruising and swelling tendencies. Minimally invasive treatments often involve short-term swelling or bruising, while surgery generally involves a longer recovery window. Many clinicians advise planning for variability rather than assuming a fixed timeline.

Q: How long do results last?
Longevity depends on the method used, the patient’s anatomy, and (for fillers) the specific product. Surgical changes may last longer, but aging and tissue changes continue over time. With fat transfer, persistence varies by technique and individual biology.

Q: Are there risks specific to the under-eye area?
Yes. The under-eye region has thin skin and complex anatomy, so swelling, contour irregularities, and asymmetry can be more noticeable than in other areas. For injectables, risk profiles also depend on product choice and injection technique; clinicians typically discuss these in informed consent.

Q: Why might a clinician recommend treating the cheek instead of the tear trough?
In some faces, the tear trough appearance is driven by midface descent or lack of cheek support rather than a localized under-eye deficit. Treating the cheek can improve overall support and soften the transition between eyelid and cheek. The decision is individualized and based on facial analysis.